Retour
Fourchette du Jour
18,60 €
20,16 €
Fourchette 52 Semaines
10,01 €
24,33 €
Volume
224 125
Moyenne 50J / 200J
20,20 €
/
16,40 €
Clôture Précédente
18,92 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -13,2 | 0,3 |
| P/B | 4,6 | 3,0 |
| ROE % | -30,8 | 3,7 |
| Net Margin % | -60,0 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
30,00 €
+59.8%
BPA Prévisionnel
-1,46 €
CA Est.
113,14M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
-0,86 €
-1,03 € – -0,76 €
|
184,69M | 3 |
| FY2027 |
-1,01 €
-1,41 € – -0,69 €
|
144,59M | 7 |
| FY2026 |
-1,46 €
-1,63 € – -1,35 €
|
113,14M | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-24 | -0,41 € | -0,36 € | +12,6% |
| 2025-11-04 | -0,43 € | -0,37 € | +14,0% |
| 2025-08-05 | -0,40 € | -0,38 € | +5,0% |
| 2025-05-08 | -0,43 € | -0,36 € | +16,3% |
| 2025-02-25 | -0,32 € | -0,40 € | -25,0% |
| 2024-11-12 | -0,82 € | -1,85 € | -125,6% |
| 2024-10-11 | N/A | -1,59 € | — |
| 2024-03-31 | N/A | -1,59 € | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Debt/Equity of 0,14 — conservative balance sheet
Negative free cash flow of -41,58M
PEG of 0,26 suggests growth is underpriced
Capital efficient — spends only 0,86% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)36,09%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-30,83%
ROIC-24,66%
Net Margin-59,97%
Op. Margin-65,57%
Sécurité
Debt / Equity
0,14
Current Ratio9,73
Interest Coverage-30,90
Valorisation
P/E Ratio
-13,23
Forward P/EN/A
P/B Ratio4,55
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36,09% | Revenue Growth (3Y) | 40,33% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 89,06M | Net Income (TTM) | -53,41M |
| ROE | -30,83% | ROA | -27,28% |
| Gross Margin | 87,89% | Operating Margin | -65,57% |
| Net Margin | -59,97% | Free Cash Flow (TTM) | -41,58M |
| ROIC | -24,66% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,14 | Current Ratio | 9,73 |
| Interest Coverage | -30,90 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -13,23 | Forward P/E | N/A |
| P/B Ratio | 4,55 | P/S Ratio | 7,93 |
| PEG Ratio | 0,26 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 6,24 | Fwd Earnings Yield | N/A |
| FCF Yield | -5,88% | ||
| Market Cap | 706,53M | Enterprise Value | 688,33M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 89,06M | 65,44M | 45,23M | 25,92M |
| Net Income | -53,41M | -40,46M | -29,46M | -37,16M |
| EPS (Diluted) | -1,46 | -3,39 | -1,26 | -1,59 |
| Gross Profit | 78,27M | 56,75M | 38,16M | 21,49M |
| Operating Income | -58,40M | -39,71M | -30,04M | -36,02M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 195,80M | 225,41M | 58,92M | 86,46M |
| Total Liabilities | 40,47M | 34,25M | 171,17M | 172,86M |
| Shareholders' Equity | 155,34M | 191,17M | -112,25M | -86,40M |
| Total Debt | 22,28M | 21,96M | 14,20M | 18,22M |
| Cash & Equivalents | 40,48M | 194,37M | 34,50M | 68,24M |
| Current Assets | 186,72M | 217,27M | 51,96M | 79,80M |
| Current Liabilities | 19,19M | 12,99M | 21,60M | 9,86M |